← All organizations

Cornerstone Therapeutics

For profit

Also known as: Cornerstone Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

First clinical trial

Last known activity

Mar 1, 2013

Acquired by Chiesi on Jan 1, 2014

Timeline

2000s

Jan 1, 2003
Cornerstone Therapeutics— Founded
May 2, 2008
Critical Therapeutics— Acquired

2010s

Jan 1, 2012
EKR Therapeutics— Acquired
Jan 4, 2012
CardioKine Inc.— Acquired
Jan 1, 2014
Chiesi— Acquired By

Drugs by trial phase (7 distinct, 17 trials)

Phase 4 (0 own, 4 via acquisition)

Phase 3 (0 own, 1 via acquisition)

lixivaptan

Phase 2 (0 own, 1 via acquisition)

pyruvate

Phase 1 (0 own, 1 via acquisition)

moxifloxacin

Indications

Studied for

Asthma

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (1)

NCT01805687Lead sponsorPhase 4Mar 1, 2013

Details

Founded: Cary, NC, US Jan 1, 2003
Last known activity: Mar 1, 2013